Clinical Trial Update: Icotinib in Previously Treated Non/Light-smoking Patients With Advanced Squamous Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating icotinib in previously treated, non- or light-smoking patients with advanced squamous cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• icotinib (icotinib)

Snippet

Sponsor: Zhejiang University | Conditions: Squamous Cell Carcinoma of Lung | Phase 2 | Status: UNKNOWN